CM
LLY icon

CastleKnight Management’s Eli Lilly LLY Stock Holding History

CastleKnight Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,250
Closed -$1.75M – 338
2023
Q3 		$1.75M Sell
3,250
-650
-17% -$335K 0.11% 117
2023
Q2 		$1.83M Buy
+3,900
New +$1.64M 0.19% 88

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CastleKnight Management's LLY Position: Q4 2023 in Review

CastleKnight Management sold out of Eli Lilly (LLY) in Q4 2023, closing a stake of 3,250 shares — an estimated $1.75M sold.

CastleKnight Management first reported a position in LLY in Q2 2023 and held it in 2 quarters. The position peaked at $1.83M in Q2 2023. 3,272 funds tracked by Wall St. Rank hold LLY as of Q4 2023.

  • CastleKnight Management reported no remaining Eli Lilly position as of Q4 2023 after selling out during the quarter.
  • CastleKnight Management sold 3,250 Eli Lilly shares in Q4 2023, an estimated $1.75M.
  • CastleKnight Management first reported a position in Eli Lilly in Q2 2023 and held it in 2 quarters.
  • CastleKnight Management's Eli Lilly position peaked at $1.83M in Q2 2023.
  • 3,272 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2023.

Based on CastleKnight Management's 13F filing for Q4 2023, filed 14 Feb 2024.